- Home
- STT vs WST Comparison
STT vs WST Comparison
Compare STT & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STT
- WST
- Stock Information
- Founded
- STT 1792
- WST 1923
- Country
- STT United States
- WST United States
- Employees
- STT N/A
- WST N/A
- Industry
- STT Major Banks
- WST Medical/Dental Instruments
- Sector
- STT Finance
- WST Health Care
- Exchange
- STT Nasdaq
- WST Nasdaq
- Market Cap
- STT 27.7B
- WST 23.2B
- IPO Year
- STT N/A
- WST N/A
- Fundamental
- Price
- STT $98.20
- WST $322.35
- Analyst Decision
- STT Buy
- WST Buy
- Analyst Count
- STT 14
- WST 3
- Target Price
- STT $95.07
- WST $460.33
- AVG Volume (30 Days)
- STT 1.9M
- WST 525.4K
- Earning Date
- STT 01-17-2025
- WST 10-24-2024
- Dividend Yield
- STT 3.08%
- WST 0.26%
- EPS Growth
- STT N/A
- WST N/A
- EPS
- STT 6.30
- WST 6.74
- Revenue
- STT $12,548,000,000.00
- WST $2,876,400,000.00
- Revenue This Year
- STT N/A
- WST N/A
- Revenue Next Year
- STT $3.22
- WST $6.22
- P/E Ratio
- STT $15.64
- WST $47.21
- Revenue Growth
- STT 4.38
- WST N/A
- 52 Week Low
- STT $70.20
- WST $265.00
- 52 Week High
- STT $99.76
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- STT 60.36
- WST 54.34
- Support Level
- STT $96.69
- WST $313.92
- Resistance Level
- STT $99.76
- WST $326.58
- Average True Range (ATR)
- STT 1.28
- WST 7.45
- MACD
- STT -0.13
- WST -0.53
- Stochastic Oscillator
- STT 66.09
- WST 89.36
About STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $42 trillion in assets under custody and administration and $4.1 trillion assets under management as of Dec. 31, 2023, State Street operates globally in more than 100 geographic markets and employs more than 46,000 worldwide.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.